Socioeconomic status and epithelial ovarian cancer survival in Sweden
- 305 Downloads
To investigate socioeconomic disparities in epithelial ovarian cancer (EOC) survival in Sweden.
A cohort of 635 women with invasive EOC who participated in a nationwide population-based case–control study was included in the present population-based prospective study. Women were diagnosed with EOC between 1993 and 1995. Mortality until 31 December 2007 was determined through linkage with the Swedish Cause of Death Registry. Clinical data (tumor stage and tumor differentiation) and indicators of socioeconomic status (SES, education level, and annual individual disposable income) were retrieved from medical records and a nationwide database, respectively. The Cox proportional hazards regression model and the Laplace regression model were used to estimate the effect of clinical factors and SES on EOC survival.
The main factors associated with EOC survival were tumor stage and tumor differentiation: women with stage II, III, and IV tumors had a greater mortality risk than those with stage I tumors [hazard ratio (HR) 2.65, 95 % confidence interval (CI) 1.73–4.07; HR 6.69, 95 % CI 4.85–9.22; HR 12.84, 95 % CI 8.90–18.66, respectively]. After adjustment for these tumor characteristics, no clear association remained between our indicators of SES and EOC survival, but better survival was observed among women with stage IV tumors and a higher income level, and among women with poorly differentiated tumors and a higher education level. Nevertheless, there was no evidence of extended survival among women with higher compared to lower SES.
Our study provides no convincing evidence of an association between SES and EOC survival in Sweden.
KeywordsOvarian Cancer Survival Socioeconomic status
The authors would like to thank to all collaborating gynecologists, pathologists, and oncologists who helped to retrieve information for this study and also Mrs Pouran Almstedt, Department of Medical Epidemiology and Biostatistics, for data management, Mrs Margrethe Meo, Cancer Registry of Norway, for secretarial assistance, and Mrs Trudy Perdrix-Thoma for editorial help. No authors have any conflict of interest to declare. This study was funded by grants of the Swedish Cancer Society and Swedish Research Council.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Kogevinas M, Porta M (1997) Socioeconomic differences in cancer survival. In: Kogevinas M, Pearce M, Susser M, Boffetta P (eds) Social inequalities and cancer, vol 138. IARC Scientific Publications, International Agency for Research on Cancer, Lyon, pp 177–206Google Scholar
- 5.Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nohr B, Munk C, Kjaer SK (2008) Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2003–2017. doi: 10.1016/j.ejca.2008.06.014 PubMedCrossRefGoogle Scholar
- 10.Statistics Sweden (2013) Longitudinal integration database for health insurance and labor market studies (LISA). http://www.scb.se/Pages/List____257742.aspx. Accessed October 2013
- 13.Akeson M, Jakobsen AM, Zetterqvist BM, Holmberg E, Brannstrom M, Horvath G (2009) A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors. Int J Gynecol Cancer 19:116–123. doi: 10.1111/IGC.0b013e3181991b13 PubMedCrossRefGoogle Scholar
- 14.Official Statistics of Sweden (2010) Cancer incidence in Sweden 2010. National Board of Health and Welfare, Stockholm. www.socialstyrelsen.se
- 16.National Board of Health and Welfare [Cancer in figures 2013]. Stockholm: National Board of Health and Welfare, 2013. SwedishGoogle Scholar
- 17.Regional Cancer Center in Collaboration (2014) [National guidelines for ovarian cancer]. http://www.cancercentrum.se/sv/Vardprogram/Aggstockscancer/. Accessed 18 March 2014. Swedish